What does Ellomay Capital do?
Ellomay Capital Ltd. is an Israeli renewable-energy developer, owner and operator listed on the NYSE American and Tel Aviv Stock Exchange under ELLO. Its official company overview describes a portfolio spanning solar generation, renewable gas, pumped hydro and battery-storage development in Spain, Italy, the Netherlands, Texas and Israel. That mix makes Ellomay closer to a small infrastructure holding and development platform than to a single-technology solar producer.
The company matters because it combines mature operating assets with construction-stage and ready-to-build projects. Existing plants provide revenue, while development rights, permits, grid connections and financing structures create option value. The trade-off is capital intensity: growth requires large construction budgets, project debt and careful timing of power-purchase agreements, tax incentives and asset sales.
| Business area | Current footprint | Economic role |
|---|---|---|
| Solar generation | Spain, Italy and Texas | Electricity sales through market exposure, tariffs and PPAs; the principal consolidated revenue source. |
| Renewable gas | Three Dutch anaerobic-digestion plants | Green-gas sales, gate fees, subsidies and green certificates, with feedstock and biological-process risk. |
| Energy storage | Manara pumped storage plus battery projects in Spain, Italy and Israel | Long-duration system capacity and price-arbitrage potential, but heavy capex and permitting exposure. |
| Development platform | Italy, Texas, Spain and Israel pipeline | Creates value by moving projects from land and permits to RTB, construction and operation. |
How does Ellomay Capital make money?
Which revenue streams matter most?
Ellomay earns recurring revenue when operating plants sell electricity or renewable gas. Solar economics depend on generation volume, irradiance, capture prices, regulated tariffs and contractual hedges. Talasol, the 300 MW Spanish plant that Ellomay controls through a 51% interest, sells electricity into the market while a financial power swap covers about 80% of output. Smaller Spanish plants receive subsidized economics, Italian projects use market and PPA structures, and Texas projects combine electricity revenue with U.S. tax-credit monetization.
The Dutch plants add a different model: they process organic feedstock into green gas, receive gate fees for accepting certain inputs, and generate certificates or subsidies. Their margin can improve when gate fees rise or feedstock costs fall, but biological interruptions and heat can reduce output. Ellomay's operating-project disclosures show how the portfolio diversifies technology, geography and revenue contracts.
FY2025
What did Ellomay Capital's latest quarter show?
Why did profit swing so sharply?
The quarter ended March 31, 2026 showed stable top-line revenue but weak accounting profit. Revenue declined from €8.9 million in Q1 2025 to €8.7 million because electricity prices in Spain and Italy were low and sometimes negative. Operating expenses rose to €5.1 million from €4.6 million as Dutch energy and feedstock costs increased and new Italian and Texas assets entered operation. Depreciation rose to €4.5 million from €4.2 million.
The larger swing occurred below operating profit. Net financing expense was €8.2 million in Q1 2026 versus €7.2 million of financing income in Q1 2025. Exchange-rate effects alone moved by €13.6 million between periods as the NIS appreciated 2.9% against the euro in Q1 2026 after depreciating 5.9% in Q1 2025. That volatility shows why a simple revenue-growth view is inadequate: Ellomay reports in euros but holds NIS cash and issues NIS-denominated debentures.
| Metric | Q1 2026 | Q1 2025 | Interpretation |
|---|---|---|---|
| Revenue | €8.665M | €8.860M | New capacity did not fully offset lower European power prices. |
| Gross profit / loss | €0.928M loss | €0.005M loss | Depreciation and operating costs exceeded quarterly revenue. |
| Operating loss | €2.698M | €2.514M | Higher G&A offset lower project-development expense. |
| Net financing result | €8.220M expense | €7.221M income | Currency translation and debenture interest dominated the earnings swing. |
| Cash from operations | €1.9M used | €0.3M generated | Low prices and higher insurance and consulting costs pressured cash conversion. |
Which turning points shaped Ellomay's current strategy?
Ellomay's history is best understood as repeated recycling of capital rather than uninterrupted ownership of every asset. Management has acquired, developed, financed, operated and sometimes sold projects when it judged the proceeds could strengthen the balance sheet or fund a larger pipeline.
-
2009Renewables pivot. The company began focusing on renewable energy and power, establishing the strategic identity it retains today.
-
2017-2018Dutch biogas platform. Two anaerobic-digestion projects entered operation, adding a non-solar revenue stream with feedstock and certificate economics.
-
2019Italian portfolio sale and Talasol partnership. Ellomay sold 22.6 MW of Italian PV assets and sold 49% of Talasol, demonstrating its willingness to crystallize value while retaining control of a larger project.
-
2020-2021Scale step-up. Talasol connected to the grid in December 2020 and reached preliminary acceptance in January 2021; Ellomay also acquired the Gelderland biogas plant and closed Manara project financing.
-
2023-2025New growth regions. Ellomay entered Texas solar development and partnered with Clal on a 198 MW Italian portfolio, bringing institutional co-investment into the buildout.
-
2026Dorad exit. The company sold its indirect 16.9% economic interest in Dorad based on a NIS 4.4B valuation and redirected proceeds toward deleveraging, liquidity and renewable development.
The Dorad sale is the clearest recent example. The completed transaction produced NIS 559.8 million of consideration, while the June 2026 presentation indicated a NIS 332 million pre-tax capital gain. It also removed a profitable equity-accounted asset, so future comparisons must separate the one-time gain and discontinued Dorad contribution from the continuing renewable portfolio.
What gives Ellomay a competitive advantage?
A multi-country development and financing capability
Ellomay's advantage is not global scale. It is the ability to originate and advance projects across several regulatory systems while using partnerships and project-level financing to reduce equity requirements. The company operates in five jurisdictions, uses local tariffs and PPAs, sells U.S. tax credits, and has attracted Clal as a 49% partner in Italian projects. These capabilities are difficult for a new entrant to reproduce quickly because land rights, grid access, permits, EPC contracts and lender relationships accumulate over years.
Control of complex assets creates optionality
Ellomay controls Talasol despite owning 51%, and it owns 83.333% of Manara. Control allows management to influence financing, operating and exit decisions, while minority capital shares risk. The 2026 investor presentation also shows a shift toward storage: 1,878 MWh of storage capacity was listed in the development portfolio, including stand-alone Italian BESS, Spanish battery projects and Israeli solar-plus-storage.
For a VRIO-style interpretation, development relationships and execution experience are valuable and relatively scarce, but the advantage is not fully insulated: larger competitors have cheaper capital, bigger teams and stronger procurement leverage. Ellomay's edge therefore depends on disciplined project selection and timing rather than an unassailable moat.
Who competes with Ellomay, and where is it positioned?
Ellomay competes at several stages. It competes with Israeli-listed renewable developers such as Enlight Renewable Energy, Energix, Doral, Nofar and Econergy for capital, projects and investor attention. In Europe and the United States it also competes with local developers, global independent power producers, utilities, infrastructure funds and tax-equity investors. Supplier power can rise when transformers, panels, batteries, EPC labor or project finance are scarce; buyer power varies according to whether output is sold under a long-term contract or into a merchant market.
| Competitive dimension | Ellomay position | Strategic implication |
|---|---|---|
| Scale and cost of capital | Smaller than major listed IPPs and utilities | Partnerships, debentures and project finance are essential to compete for large assets. |
| Development pipeline | Broad relative to current revenue base | Successful conversion can transform earnings; delays can leave capital tied up without revenue. |
| Technology mix | Solar, biogas, pumped storage and batteries | Diversification reduces single-technology dependence but raises operational complexity. |
| Contracting | Combination of tariffs, PPAs, hedges and merchant exposure | Provides upside and risk diversification, but makes consolidated margins less predictable. |
| Asset recycling | Demonstrated through Italian assets, Talmei Yosef and Dorad | Can fund growth without permanent ownership, provided sales occur above invested capital. |
How financially strong is Ellomay Capital?
FY2025 profitability was positive at the gross line but weak after financing
The audited 2025 Form 20-F reported €42.8 million of revenue and €6.9 million of gross profit, equivalent to a 16.2% gross margin after operating expenses and depreciation. Continuing operations then absorbed project-development and corporate costs. Net financing expense reached €27.4 million, while €16.9 million of discontinued-operation profit from the Dorad investment partly offset the continuing loss. The final audited net loss was approximately €6.4 million.
The balance sheet is large because projects are capital intensive
At March 31, 2026, Ellomay had €885.4 million of assets, €726.5 million of liabilities and €158.9 million of equity. Cash was €83.7 million, but gross bank, other-loan and debenture obligations exceeded €640 million when current and long-term balances are combined. Much of that debt is project-related, yet it still affects refinancing risk, interest expense and covenant capacity.
| Balance-sheet item | March 31, 2026 | December 31, 2025 | Research implication |
|---|---|---|---|
| Cash and equivalents | €83.7M | €87.6M | Pre-Dorad-sale liquidity remained meaningful but was small relative to construction commitments. |
| Total assets | €885.4M | €843.5M | Asset growth reflects continuing investment in construction-stage projects. |
| Total liabilities | €726.5M | €678.4M | Leverage and project funding drive a large share of enterprise value sensitivity. |
| Total equity | €158.9M | €165.1M | The Q1 comprehensive loss reduced the equity buffer before the Dorad transaction closed. |
| Fixed assets | €585.4M | €566.9M | High fixed assets mean depreciation, capex and project utilization must be modeled explicitly. |
How do ownership, governance and capital allocation affect the story?
Ownership is concentrated despite one-share-one-vote rights
Ellomay has one ordinary share class with one vote per share, but its shareholder base is not fully dispersed. The September 2025 annual-meeting materials reported 13,779,585 ordinary shares outstanding and 258,046 treasury shares. Shlomo Nehama beneficially owned 26.0%, Kanir Joint Investments 18.9%, and their shareholder agreement created shared voting power over 41.6% of outstanding shares. CEO Ran Fridrich is connected to Kanir's general partner, so governance and operating leadership are linked.
| Holder or group | Reported beneficial ownership | Source period | Why it matters |
|---|---|---|---|
| Shlomo Nehama | 3,588,577 shares; 26.0% | September 10, 2025 | Large strategic shareholder and party to the voting agreement. |
| Kanir Joint Investments | 2,605,845 shares; 18.9% | September 10, 2025 | Connected to CEO Ran Fridrich through the general partner. |
| Clal Insurance | 1,940,045 shares; 13.6% | August 2025 filing basis | Institutional shareholder and project partner in the Italian portfolio. |
| Yelin Lapidot | 1,632,040 shares; 11.8% | Latest proxy disclosure | Represents managed funds rather than a single operating sponsor. |
| Phoenix / Menora | 9.5% / 7.1% | Latest proxy disclosure | Adds an institutional investor base, but concentrated strategic holders retain strong influence. |
The Dorad proceeds reset capital allocation
The company used approximately NIS 170 million to repay Series E secured debentures early. Its presentation allocated roughly 60% of net proceeds to balance-sheet strengthening and financial flexibility, with 40% earmarked for growth investments. That policy is rational for a developer with a large pipeline: deleveraging lowers refinancing pressure, while retained cash can serve as equity beneath project loans.
Which opportunities and risks could change Ellomay's outlook?
Growth depends on converting the pipeline into operating cash flow
Italy is the largest near-term growth engine. Ellomay reported 160 MW under construction with planned completion by the end of 2026 and 210 MW at RTB status. About 100 MW won FER X tenders with 20-year electricity-sale contracts, which can improve revenue visibility. In the Netherlands, licensed capacity expansion could increase annual green-gas output from about 16 million cubic meters to around 24 million. Texas offers tax-credit-supported growth, while Spanish batteries could reduce the damage caused by low midday prices.
The risk set is unusually interconnected
The same factors that create upside also create downside. Merchant electricity prices can fall when renewable output is abundant. Construction delays postpone revenue but continue interest capitalization and overhead. Interest rates affect project finance and debentures. Currency movements can produce large accounting gains or losses. War-related conditions have already stopped work at Manara's upper and lower reservoir sites even while tunneling continued. Dutch plants face feedstock, biological-process and regulatory timing risk, while U.S. projects face tariff and tax-policy uncertainty.
| Risk or opportunity | Financial line affected | Evidence to monitor |
|---|---|---|
| Low European power prices | Revenue, gross profit and operating cash flow | Realized price, capture rate, negative-price hours and storage deployment. |
| Pipeline conversion | Fixed assets, capex, depreciation and future revenue | RTB milestones, notice to proceed, financing close and commercial operation dates. |
| Currency and rates | Financing result, equity reserves and interest expense | NIS/euro movement, debt issuance terms and hedge balances. |
| Storage buildout | Capex and long-term revenue quality | Permits, contracted capacity payments, arbitrage assumptions and battery costs. |
| Geopolitical disruption | Manara schedule, claims and project cost | Construction resumption, regulator compensation and revised completion budget. |
Why does Ellomay's business model matter for valuation?
A single consolidated DCF can hide the economics
Ellomay is better analyzed with a sum-of-the-parts framework. Operating solar and biogas assets can be valued from production, realized prices, operating costs, maintenance capex, taxes and project debt. Construction-stage assets need probability-adjusted completion dates, remaining capex and financing assumptions. RTB and development projects deserve lower values until permits, contracts and funding are secured. Manara requires a separate long-duration model because its €615 million expected project cost, 2030 completion target and 1,872 MWh storage capacity are fundamentally different from solar economics.
| Valuation block | Primary drivers | Common modeling mistake |
|---|---|---|
| Operating Spain solar | Generation, capture price, Talasol hedge, degradation and project debt | Applying a constant market price without hourly capture-price pressure. |
| Dutch biogas | Output, gas price, certificates, gate fees, feedstock and uptime | Treating revenue as solar-like when biological and commodity inputs matter. |
| Italy and Texas growth | COD timing, PPA or tariff, tax credits, capex and partner ownership | Valuing gross project MW as though Ellomay owned 100% of every asset. |
| Manara storage | Completion cost, availability revenue, financing and delay compensation | Ignoring construction risk because expected annual revenue is disclosed. |
| Parent balance sheet | Cash, debentures, corporate costs, NCI and post-Dorad proceeds | Subtracting all project debt twice or omitting minority interests. |
Which KPIs belong in the model?
The valuation is therefore most sensitive to commissioning dates, European price capture, financing cost and how efficiently the Dorad proceeds are reinvested. Reported EBITDA is useful for operating comparison, but it excludes capex and can include equity-accounted or one-time effects; free cash flow and attributable project economics are more decision-useful.
What is the key takeaway from Ellomay Capital analysis?
Ellomay is a concentrated, capital-intensive renewable infrastructure platform with more project ambition than its current revenue base suggests. Its operating assets provide a foundation, but the investment case is driven by project conversion: completing 160 MW in Italy, advancing 210 MW of RTB capacity, expanding Dutch green gas, connecting Texas projects and eventually delivering Manara. The May 2026 Dorad sale materially improved financial flexibility and demonstrated asset-sale value creation, while also removing a profitable investee and making historical earnings less comparable.
The strongest support for the story is management's record of moving assets through development, financing and monetization. The principal weakness is that leverage, capex, currency movements and merchant power prices can overwhelm modest changes in revenue. Students and researchers should therefore treat Ellomay as an infrastructure case study in capital allocation, project finance and portfolio rotation rather than as a conventional growth company.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
